Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review
Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency, but also robust antiinflammatory and regenerative properties. After widespread in-vitro and in-vivo preclinical testing, autologous and allogeneic MSCs have been applied in a range of immune mediated conditions,...
Main Authors: | Fernando E Figueroa, Flavio Carrión, Sandra Villanueva, Maroun Khoury |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-01-01
|
Series: | Biological Research |
Subjects: | |
Online Access: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602012000300008 |
Similar Items
-
IL17/IL17RA as a Novel Signaling Axis Driving Mesenchymal Stem Cell Therapeutic Function in Experimental Autoimmune Encephalomyelitis
by: Mónica Kurte, et al.
Published: (2018-04-01) -
Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases
by: Ziwei Shen, et al.
Published: (2021-09-01) -
Mesenchymal stem cells for treating autoimmune dacryoadenitis
by: Xiaoxiao Lu, et al.
Published: (2017-06-01) -
Application of mesenchymal stem cells in paediatrics
by: Wawryk-Gawda Ewelina, et al.
Published: (2017-09-01) -
Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune Diseases
by: Shohreh Hajizadeh-Sikaroodi, et al.
Published: (2014-04-01)